RxDoctor Payments DataLook up a doctor →

Bradford Fine, DPM

Foot & Ankle Surgery · Lexington, KYNPI 1659319721

Payments from drug & device makers

$82,138in general payments, 2019–2025

Across 520 payments — averaging $157.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$73K
  • Stryker$2K
  • Medartis Inc.$1K
  • Integra Lifesciences Corporation$724
  • Paratek Pharmaceuticals, Inc.$660
  • Treace Medical Concepts, Inc.$571
  • plus $4K from 46 others

What the payments were for

  • Consulting fees$3,0204%
  • Speaking & faculty fees$51,06062%
  • Travel & lodging$15,33519%
  • Food & beverage$12,31215%
  • Education$490%
  • Gifts$3630%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$82,138 in reported general payments places this provider in the 95th percentile of 141 foot & ankle surgery providers in Kentucky.

See all foot & ankle surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$175,712
Medicare patients
533
Services billed
2,976

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SantylCollagenase Clostridium Hist.37$13,910
Doxycycline Monohydrate257$6,732
Enoxaparin Sodium22$4,234
Ketoconazole44$960
Nystatin31$701
Gabapentin82$553
Pregabalin31$535
Allopurinol92$459
Promethazine Hcl30$327
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav32$301
Doxycycline Hyclate32$284
Diclofenac Sodium18$205
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim21$193
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen42$169
Ciprofloxacin Hcl18$158

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Smith+NephewSantyl$72,929$13,91037 claims
SandozEnoxaparin Sodium$19$4,23422 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 141 foot & ankle surgery providers in Kentucky.

Other foot & ankle surgery in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →